<SEC-DOCUMENT>0001144204-17-010121-index.html : 20170221
<SEC-HEADER>0001144204-17-010121.hdr.sgml : 20170220
<ACCEPTANCE-DATETIME>20170221154402
ACCESSION NUMBER:		0001144204-17-010121
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20170216
FILED AS OF DATE:		20170221
DATE AS OF CHANGE:		20170221

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TITAN PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000910267
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943171940
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		400 OYSTER POINT BLVD
		STREET 2:		SUITE 505
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		6502444990

	MAIL ADDRESS:	
		STREET 1:		400 OYSTER POINT BLVD
		STREET 2:		SUITE 505
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			MACFARLANE M DAVID
		CENTRAL INDEX KEY:			0001182314

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13341
		FILM NUMBER:		17624938

	MAIL ADDRESS:	
		STREET 1:		C/O TITAN PHARMACEUTICALS INC
		STREET 2:		400 OYSTER POINT BLVD
		CITY:			S SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>v459917_4.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: v459917_4.html

Document 1 - RAW XML: v459917_4.xml

</DOCUMENT>
</SEC-DOCUMENT>